Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice

• Main Authors: Selma Atalay (Author), Lara S. van der Schoot (Author), Laura Vandermaesen (Author), Lieke J. van Vugt (Author), Mascha Eilander (Author), Juul M.P.A. van den Reek (Author), Elke M.G.J. de Jong (Author)
• Format: Book
• Published: Medical Journals Sweden, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dose reduction of biologics for psoriasis could contribute to lower drug exposure. This study evaluated a one-step, tightly controlled, biologic dose reduction strategy in a prospective daily practice cohort. In patients with psoriasis with low disease activity using adalimumab, etanercept or usteki...